Formica V - Search Results

1

Concordance of Blood-Based and Normal Tissue-Based Dihydropyrimidine Dehydrogenase (DPYD) Genotyping.

Morelli C, Formica V, Doldo E, Riondino S, Rofei M, Vergilii L, Palmieri G, Arkenau HT, Roselli M, Orlandi A. Morelli C, et al. Among authors: formica v. Oncologist. 2022 May 6;27(5):e420-e421. doi: 10.1093/oncolo/oyac057. Oncologist. 2022. PMID: 35325223 Free PMC article.

2

Non-steroidal anti-inflammatory drugs in cancer prevention and therapy.

Guadagni F, Ferroni P, Palmirotta R, Del Monte G, Formica V, Roselli M. Guadagni F, et al. Among authors: formica v. Anticancer Res. 2007 Sep-Oct;27(5A):3147-62. Anticancer Res. 2007. PMID: 17970056 Free article. Review.

3

The Medical Care Continuity (MCC) project. A pilot study of video-assisted home care within the eTEN European Community program. The Italian experience.

Formica V, Fossile E, Pellegrino R, Fatale M, Mari M, Rabuffetti M, Benedetto FR, Visconti G, Bollero E, Roselli M. Formica V, et al. Support Care Cancer. 2009 May;17(5):471-8. doi: 10.1007/s00520-008-0559-1. Epub 2008 Dec 17. Support Care Cancer. 2009. PMID: 19089459

4

Thromboembolic events in patients treated with anti-angiogenic drugs.

Ferroni P, Formica V, Roselli M, Guadagni F. Ferroni P, et al. Among authors: formica v. Curr Vasc Pharmacol. 2010 Jan;8(1):102-13. doi: 10.2174/157016110790226660. Curr Vasc Pharmacol. 2010. PMID: 19485903 Free article. Review.

5

Prognostic significance of serum adipokine levels in colorectal cancer patients.

Guadagni F, Roselli M, Martini F, Spila A, Riondino S, D'Alessandro R, Del Monte G, Formica V, Laudisi A, Portarena I, Palmirotta R, Ferroni P. Guadagni F, et al. Among authors: formica v. Anticancer Res. 2009 Aug;29(8):3321-7. Anticancer Res. 2009. PMID: 19661351 Free article.

6

Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients.

Formica V, Massara MC, Portarena I, Fiaschetti V, Grenga I, Del Vecchio Blanco G, Sileri P, Tosetto L, Skoulidis F, Pallone F, Roselli M. Formica V, et al. Cancer Biomark. 2009;5(4):167-75. doi: 10.3233/CBM-2009-0101. Cancer Biomark. 2009. PMID: 19729826

7

Caregiver distress in the early phases of cancer.

Pellegrino R, Formica V, Portarena I, Mariotti S, Grenga I, Del Monte G, Roselli M. Pellegrino R, et al. Among authors: formica v. Anticancer Res. 2010 Nov;30(11):4657-63. Anticancer Res. 2010. PMID: 21115920

8

Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab.

Formica V, Palmirotta R, Del Monte G, Savonarola A, Ludovici G, De Marchis ML, Grenga I, Schirru M, Guadagni F, Roselli M. Formica V, et al. Int J Colorectal Dis. 2011 Feb;26(2):143-51. doi: 10.1007/s00384-010-1108-1. Epub 2010 Dec 29. Int J Colorectal Dis. 2011. PMID: 21188390

9

Rehabilitation in neuro-oncology: a meta-analysis of published data and a mono-institutional experience.

Formica V, Del Monte G, Giacchetti I, Grenga I, Giaquinto S, Fini M, Roselli M. Formica V, et al. Integr Cancer Ther. 2011 Jun;10(2):119-26. doi: 10.1177/1534735410392575. Epub 2010 Dec 31. Integr Cancer Ther. 2011. PMID: 21196433 Free article.

10

Insulinemia and the risk of breast cancer and its relapse.

Formica V, Tesauro M, Cardillo C, Roselli M. Formica V, et al. Diabetes Obes Metab. 2012 Dec;14(12):1073-80. doi: 10.1111/j.1463-1326.2012.01614.x. Epub 2012 May 17. Diabetes Obes Metab. 2012. PMID: 22537210 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page